Contraception options: Aspects unique to adolescent and young adult

Family Planning 2020, 2017 Apter, 2012, Adolescent contraception, Endocr Dev, 22, 287, 10.1159/000326704 Diedrich, 2017, Long-acting reversible contraception in adolescents: a systematic review and meta-analysis, Am J Obstet Gynecol, 216, 364.e1, 10.1016/j.ajog.2016.12.024 World Health Organization W, 2015 Lehti, 2013, Association between childhood psychosocial factors and induced abortion, Eur J Contracept Reprod Health Care, 166, 190 Kirby, 2007, Sex and HIV education programs: their impact on sexual behaviors of young people throughout the world, J Adolesc Health, 40, 206, 10.1016/j.jadohealth.2006.11.143 Kirby, 2008, The impact of abstinence and comprehensive sex and STD/HIV education programs on adolescent sexual behavior, Sex Res Soc Policy, 5, 18, 10.1525/srsp.2008.5.3.18 World Health Organization (WHO), 2010 Ketting, 2016, Evaluation of holistic sexuality education: a European expert group consensus agreement, Eur J Contracept Reprod Health Care, 21, 68, 10.3109/13625187.2015.1050715 Apter, 2016, Sexuality education programmes and sexual health services: links for better sexual and reproductive health (SRH), Entre Nous, 69, 12 Bitzer, 2016, Targeting factors for change: contraceptive counselling and care of female adolescents, Eur J Contracept Reprod Health Care, 21, 417, 10.1080/13625187.2016.1237629 ACOG Committee Opinion No 710, 2017, Counseling adolescents about contraception, Obstet Gynecol, 130, 486, 10.1097/AOG.0000000000002228 Hindin, 2017, Country-specific data on the contraceptive needs of adolescents, Bull World Health Organ, 95, 166, 10.2471/BLT.16.189829 Lindh, 2017, Contraceptive use in the Nordic countries, Acta Obstet Gynecol Scand, 96, 19, 10.1111/aogs.13055 Faculty of Sexual and Reproductive Healthcare, 2016 Curtis, 2016, US medical eligibility criteria for contraceptive use, MMWR Recomm Rep, 2016, 65 World Health Organization, 2016 Faculty of Sexual & Reproductive Healthcare, 2015 Weller, 2002, Condom effectiveness in reducing heterosexual HIV transmission, Cochrane Libr Faculty of Sexual and Reproductive Healthcare, 2015 Niccolai, 2005, Condom effectiveness for prevention of Chlamydia trachomatis infection, Sex Transm Infect, 81, 323, 10.1136/sti.2004.012799 Martinez, 2011, Teenagers in the United States: sexual activity, contraceptive use, and childbearing, 2006-2010 national survey of family growth, Vital Health Stat 23, 31, 1 Trussell, 2012, Update on and correction to the cost-effectiveness of contraceptives in the United States, Contraception, 85, 611, 10.1016/j.contraception.2012.02.009 Gallo, 2006, Non-latex versus latex male condoms for contraception, Cochrane Database Os Syst Rev, 1 Ott, 2014, Committee on adolescence. Contraception for adolescents, Pediatrics, 134, e1257, 10.1542/peds.2014-2300 Faculty of Sexual & Reproductive Healthcare Cleland, 2012, The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience, Hum Reprod, 27, 1994, 10.1093/humrep/des140 Akintomide, 2014, Emergency intrauterine device insertion in teenagers: an informal retrospective study, J Fam Plann Reprod Health Care, 40, 196, 10.1136/jfprhc-2013-100813 Glasier, 2010, Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis, Lancet, 375, 555, 10.1016/S0140-6736(10)60101-8 Brache, 2013, Ulipristal acetate prevents ovulation more effectively than levonorgestrel: analysis of pooled data from three randomized trials of emergency contraception regimens, Contraception, 88, 611, 10.1016/j.contraception.2013.05.010 Brache, 2015, A prospective, randomized, pharmacodynamic study of quick-starting a desogestrel progestin-only pill following ulipristal acetate for emergency contraception, Hum Reprod, 30, 2785 Kapp, 2015, Effect of body weight and BMI on the efficacy of levonorgestrel emergency contraception, Contraception, 91, 97, 10.1016/j.contraception.2014.11.001 European Medicines Agency (EMA), 2014, Committee for medicinal products for human use (CHMP) European Medicines Agency (EMA), 2013, Committee for medicinal products for human use (CHMP) Dinger, 2011, Effectiveness of oral contraceptive pills in a large US cohort comparing progestogen and regimen, Obstet Gynecol, 117, 33, 10.1097/AOG.0b013e31820095a2 Howard, 2014, Comparison of pregnancy rates in users of extended and cyclic combined oral contraceptive (COC) regimens in the United States: a brief report, Contraception, 89, 25, 10.1016/j.contraception.2013.09.007 Dieben, 2002, Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring, Obstet Gynecol, 100, 585 National Institute for Health and Clinical Excellence, 2014 Faculty of Sexual & Reproductive Healthcare, 2017 Charlton, 2016, Maternal use of oral contraceptives and risk of birth defects in Denmark: prospective, nationwide cohort study, BMJ, 352, h6712, 10.1136/bmj.h6712 Faculty of Sexual & Reproductive Healthcare, 2015 Heinemann, 2015, Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the european active surveillance study for intrauterine devices, Contraception, 91, 280, 10.1016/j.contraception.2015.01.011 American College of Obstetricians and Gynecologists, 2012, Adolescents and long-acting reversible contraception: implants and intrauterine devices. Committee opinion no 539, Obstet Gynecol, 120, 983, 10.1097/AOG.0b013e3182723b7d Committee on Adolescence, 2014, Contraception for adolescents, Pediatrics, 134, e1244, 10.1542/peds.2014-2299 Curtis, 2016, Removing medical barriers to contraception—evidence-based recommendations from the Centers for Disease Control and Prevention, Contracept 2016, 94, 579 Gemzell-Danielsson, 2017, Evaluation of a new, low-dose levonorgestrel intrauterine contraceptive system over 5 years of use, Eur J Obstet Gynecol Reprod Biol, 210, 22, 10.1016/j.ejogrb.2016.11.022 Gemzell-Danielsson, 2012, A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena, Fertil Steril, 97, 616, 10.1016/j.fertnstert.2011.12.003 Gemzell-Danielsson, 2016, A Phase III, single-arm study of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5 mg) in postmenarcheal adolescents, Contraception, 93, 507, 10.1016/j.contraception.2016.02.004 Apter, 2016, A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant, Fertil Steril, 106, 151, 10.1016/j.fertnstert.2016.02.036 Sufrin, 2014, Testing for sexually transmitted infections at intrauterine device insertion: an evidence-based approach, Clin Obstet Gynecol, 57, 682, 10.1097/GRF.0000000000000054 Whiteman, 2013, When can a woman have an intrauterine device inserted? A systematic review, Contraception, 87, 666, 10.1016/j.contraception.2012.08.015 Nilsson, 1982, Clinical performance of a new levonorgestrel-releasing intrauterine device. A randomized comparison with a nova-T-copper device, Contraception, 25, 345, 10.1016/0010-7824(82)90092-0 Abou-Setta, 2013, Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery, Cochrane Libr Gupta, 2013, Levonorgestrel intrauterine system versus medical therapy for menorrhagia, N Engl J Med, 368, 128, 10.1056/NEJMoa1204724 Merki-Feld, 2017, ESC expert statement on the effects on mood of the natural cycle and progestin-only contraceptives, Eur J Contracept Reprod Health Care, 07/21, 1 Nelson, 2013, Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial, Obstet Gynecol, 122, 1205, 10.1097/AOG.0000000000000019 Heinemann, 2017, IUD use among parous women and risk of uterine perforation: a secondary analysis, Contraception, 95, 605, 10.1016/j.contraception.2017.03.007 Jatlaoui, 2017, The safety of intrauterine devices among young women: a systematic review, Contraception, 95, 17, 10.1016/j.contraception.2016.10.006 Gemzell-Danielsson, 2015, The effect of age, parity and body mass index on the efficacy, safety, placement and user satisfaction associated with two low-dose levonorgestrel intrauterine contraceptive systems: subgroup analyses of data from a phase III trial, PloS one, 10, 10.1371/journal.pone.0135309 Kaislasuo, 2014, Predicting painful or difficult intrauterine device insertion in nulligravid women, Obstet Gynecol, 124, 345, 10.1097/AOG.0000000000000362 Allen, 2009, Interventions for pain with intrauterine device insertion, Cochrane Database Syst Rev, 3, 10.1002/14651858.CD007373.pub2